We collaborate with rare disease foundations, academic scientists and other companies to develop clinical candidates for rare or neglected diseases.
Collaborations Pharmaceuticals, Inc. offers drug discovery skills tailored to rare and neglected diseases. Given our domain knowledge, we have noted the need for computational, chemical, and biological capabilities as foundations and patient-driven collaborations seek to translate a therapeutic concept. We share this desire and drive to bring therapies to market.
We provide decades of drug discovery experience to find the most cost- and time-effective routes to a much needed drug therapy.
We work with disease foundations, academics or companies to increase the probability of successful discovery outcomes.
A key aspect of bringing a therapy to market is finding the initial funds to make this happen. We have a proven track record of obtaining funding through the NIH and DOD.
Proof of concept work using machine learning for bacteria, viruses and parasites demonstrates we can identify molecules with potential in vivo activity that can lead to NIH funding to build our pipeline of drug candidates.
These projects are available for partnering - please contact us.